Drugs for Pregnant and Lactating Women E-BookDrugs for Pregnant and Lactating Women, 2nd Edition, by Carl P. Weiner, MD, MBA, FACOG, and Catalin Buhimschi, MD, is a must-have reference that details how virtually all of today’s drugs and herbal supplements interact with pregnancy and lactation. Updated thoroughly and covering nearly 2,000 substances, the new edition explains whether each drug is FDA-approved for use by expecting or nursing mothers...is known to be safe for use...or is known to pose a danger. An alphabetical organization by both trade and generic name...a special index listing drugs by category...and an easy-to-read page format make reference more efficient.Describes each substance's mechanism of action, side effects, drug-drug interactions, dosage, cost of therapy, and degree of safety during pregnancy or lactation, providing the thorough details you need to choose the most effective course of treatment. Indicates not only whether the FDA has approved a drug based on clinical trials, but also whether the drug is generally considered to be safe in the absence of FDA approval. Includes over-the-counter drugs and alternative medications as well as prescription drugs, to give you a broad background of available drugs. Features an alphabetical organization by both trade and generic name...a special index listing drugs by category...and an easy-to-read page format that make reference more efficient. Uses an eye-catching icon to highlight known teratogens. Examines new drugs that have been introduced to the market since the publication of the previous edition, and presents revised or new information for all current listings, to keep you current. Provides drug interaction information to make you aware of the possible implications of using more than one drug in combination. Includes international drug names to give this reference an international perspective. |
Contents
Chapter A | 1 |
Chapter B | 80 |
Chapter C | 120 |
Chapter D | 252 |
Chapter E | 339 |
Chapter F | 384 |
Chapter G | 438 |
Chapter H | 464 |
Chapter S | 1016 |
Chapter T | 1065 |
Chapter U | 1141 |
Chapter V | 1145 |
Chapter W | 1175 |
Chapter Z | 1179 |
Abbreviations | 1193 |
Appendix I List of Pregnancy Registries | 1206 |
Chapter I | 490 |
Chapter K | 551 |
Chapter L | 559 |
Chapter M | 616 |
Chapter N | 747 |
Chapter O | 810 |
Chapter P | 841 |
Chapter Q | 966 |
Chapter R | 974 |
Appendix II FDA Pregnancy Risk Categories and Percentage of Drugs in Each | 1212 |
Appendix III Timing of Development of Major Body Structures in the Embryo and Fetus | 1213 |
Appendix IV Critical Periods in Human Development | 1214 |
Appendix V Examples of Known or Likely Teratogens or Fetal Toxins | 1215 |
Appendix VI Injectable Hypoglycemic Agents | 1216 |
Appendix VII Effect of Pregnancy on Cytochrome P450 Isoenzymes | 1217 |
INDEX | 1219 |
Other editions - View all
Common terms and phrases
adequate reports administration agents alternative Argentina associated Australia Austria Belgium benefit justifies Brazil Breastfeeding Safety Canada Clin clinically Colombia concentrations considered Contraindications—hypersensitivity to drug crosses the human decrease Denmark disease Dosage with Qualifiers dose Drug Class Drug Interactions drug or class dysfunction Ecuador England enters human breast et al Fetal Considerations Finland France Germany glucose Greece headache hepatic higher Hong Kong human breast milk human fetuses human placenta hypertension hypothyroidism increase India Indications Indonesia infections Inhibits International Brand Ireland Israel Italy Japan justifies the potential Korea Lactation Category levels Malaysia Maternal Considerations Mechanism Mexico neonatal Netherlands NOTE nursing women Obstet Gynecol pain Panama patients Peru Philippines plasma potential perinatal risk pregnancy and lactation Pregnancy Category pregnant women published experience reduce References renal reports or well-controlled Rodent studies Side effects include Singapore South Africa Spain studies in human Summary Sweden Switzerland Taiwan Thailand treatment unknown well-controlled studies Zealand